Tag: Press Release

WIN International Molecular Tumor Board Recommends Tailored Treatment for Advanced Colorectal Cancer

June 24, 2025

“This case emphasizes the critical role of comprehensive molecular profiling and personalized therapeutic approaches in managing complex mCRC.” BUFFALO, NY - June 24, 2025 – A new precision oncology paper… read more

Oncotarget

CHEK2 Identified as a Potential Target to Improve Immunotherapy in Solid Tumors

June 20, 2025

“Taken together, CHEK2 expression has the potential to predict resistance or non-response to immunotherapy.” BUFFALO, NY - June 20, 2025 – A new review was published in Volume 16 of… read more

Oncotarget

Rare Pancreatic Cancer Patients Show Strong Response to Immunotherapy

June 17, 2025

“Our case series adds to published data from early-phase trials supporting the promise of immunotherapy in some patients with PC.” BUFFALO, NY - June 17, 2025 – A new research… read more

Oncotarget

Balancing Time, Cost, and Quality in Cardio-Oncology Care

June 13, 2025

“The unattainable triangle, also known as the iron triangle or triple constraint, traditionally applied in business as a model for balancing time, cost, and quality, offers valuable insight into the… read more

Oncotarget

Rare Non-Small Cell Lung Cancer with Brain Metastases Responds to Amivantamab Monotherapy

June 11, 2025

“This case challenges current paradigms, demonstrating that amivantamab monotherapy can effectively target rare EGFR mutations, achieve durable extracranial and CNS disease control, and potentially overcome blood-brain barrier limitations.” BUFFALO, NY… read more

Oncotarget

Oncotarget Sponsors Open Access Team in 2025 Ride for Roswell

June 10, 2025

Impact Journals, the publisher of Oncotarget, is once again proudly sponsoring the Open Access Team in the annual Ride for Roswell. BUFFALO, NY — June 10, 2025 — The Ride… read more

Oncotarget

Cigarette Smoke and DNA Repair Deficiency Drive Lung Cancer Development

June 9, 2025

“In this study, we investigated the interplay between cigarette smoke, DNA damage and repair, focusing on the Nucleotide Excision Repair (NER) protein Xeroderma Pigmentosum Group C (XPC).” BUFFALO, NY -… read more

Oncotarget

Targeting PCNA-Androgen Receptor Interaction Suppresses Prostate Cancer Cell Growth

June 4, 2025

“This finding implicates that targeting PCNA/AR interaction could be an innovative strategy for therapy against CRPC.” BUFFALO, NY - June 4, 2025 – A new research paper was published in… read more